Pros-IT CNR: an Italian prostate cancer monitoring project

Pierfrancesco Bassi, Ilaria Stefania Maggi, Angelo Porreca, Ilaria Stefania Maggi, Angelo Porreca, Anna Rita Alitto, Cynthia Aristei, Giorgio Bruno Cristiano Baldari, Francesco Catucci, Rolando Maria D'Angelillo, Daniele D'Agostino, Stefano De Luca, Giovanna Mantini, Ercole Mazzeo, Francesco Pinto, Dario Pugliese, Lucio Trodella, Marianna Noale, Stefania Maggi, Walter ArtibaniFilippo Bertoni, Sergio Bracarda, Giario Natale Conti, Renzo Corvò, Mauro Gacci, Pierpaolo Graziotti, Stefano Maria Magrini, Riccardo Maurizi Enrici, Vincenzo Mirone, Rodolfo Montironi, Giovanni Muto, Stefano Pecoraro, Umberto Ricardi, Andrea Tubaro, Vittorina Zagonel, Filiberto Zattoni, Gaetano Crepaldi

Risultato della ricerca: Contributo in rivistaArticolo in rivista

28 Citazioni (Scopus)

Abstract

Aims: The Pros-IT CNR project aims to monitor a sample of Italian males ≥18 years of age who have been diagnosed in the participating centers with incident prostate cancer, by analyzing their clinical features, treatment protocols and outcome results in relation to quality of life. Methods: Pros-IT CNR is an observational, prospective, multicenter study. The National Research Council (CNR), Neuroscience Institute, Aging Branch (Padua) is the promoting center. Ninety-seven Italian centers located throughout Italy were involved. The field study began in September 1, 2014. Subjects eligible were diagnosed with biopsy-verified prostate cancer, naïve. A sample size of 1500 patients was contemplated. A baseline assessment including anamnestic data, clinical history, risk factors, the initial diagnosis, cancer staging information and quality of life (Italian UCLA Prostate Cancer Index; SF-12 Scale) was completed. Six months after the initial diagnosis, a second assessment evaluating the patient’s health status, the treatment carried out, and the quality of life will be made. A third assessment, evaluating the treatment follow-up and the quality of life, will be made 12 months after the initial diagnosis. The 4th, 5th, 6th and 7th assessments, similar to the third, will be completed 24, 36, 48 and 60 months after the initial diagnosis, respectively, and will include also a Food Frequency Questionnaire and the Physical Activity Scale for the Elderly. Discussion: The study will provide information on patients’ quality of life and its variations over time in relation to the treatments received for the prostate cancer.
Lingua originaleEnglish
pagine (da-a)165-172
Numero di pagine8
RivistaAging clinical and experimental research
Volume29
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Adult
  • Aged
  • Aging
  • Biopsy
  • Disease Management
  • Geriatrics and Gerontology
  • Health Status
  • Humans
  • Italian UCLA Cancer Index
  • Italy
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prospective Studies
  • Prostate cancer
  • Prostate cancer treatments
  • Prostatic Neoplasms
  • Quality of Life
  • Quality of life
  • SF-12 Scale

Fingerprint Entra nei temi di ricerca di 'Pros-IT CNR: an Italian prostate cancer monitoring project'. Insieme formano una fingerprint unica.

Cita questo